HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alternative pathway complement activation in rheumatoid arthritis.

Abstract
Serum and synovial fluid (SF) levels of the complement components C3, C5, factor B (B), properdin (P), beta 1H and C3b inactivator (C3bINA), and EDTA-plasma and SF concentrations of C3d and Ba were measured in 40 rheumatoid arthritis (RA) and 5 patients with osteoarthritis. Decreased SF concentration of B and P and increased levels of Ba showed that increased alternative pathway turnover occurred in RA. Reduced SF C3bINA concentrations occurred, but levels of beta 1H were not reduced. The results showed that alternative pathway turnover was dependent upon C3 turnover, but failed to support the notion that levels of C3bINA or beta 1H control alternative pathway turnover in RA.
AuthorsA El-Ghobarey, K Whaley
JournalThe Journal of rheumatology (J Rheumatol) 1980 Jul-Aug Vol. 7 Issue 4 Pg. 453-60 ISSN: 0315-162X [Print] Canada
PMID6158571 (Publication Type: Journal Article)
Chemical References
  • Beta-Globulins
  • Complement C3
  • Complement C5
  • Properdin
  • Complement System Proteins
  • Complement Factor B
Topics
  • Arthritis, Rheumatoid (immunology)
  • Beta-Globulins (analysis)
  • Complement Activation
  • Complement C3 (metabolism)
  • Complement C5 (metabolism)
  • Complement Factor B (analysis)
  • Complement Pathway, Alternative
  • Complement System Proteins (analysis)
  • Humans
  • Properdin (analysis)
  • Synovial Fluid (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: